Does 23andMe's decline show genetic-based medicine has been overhyped?
23andMe's DNA test was once named "invention of the year", but now the company is in dire financial straits. Is this a sign that genetically based medicine's promise has been exaggerated?
![Does 23andMe's decline show genetic-based medicine has been overhyped?](https://images.newscientist.com/wp-content/uploads/2024/02/29102607/SEI_193389652.jpg)
What's Your Reaction?
![like](https://news.sciencex.in/assets/img/reactions/like.png)
![dislike](https://news.sciencex.in/assets/img/reactions/dislike.png)
![love](https://news.sciencex.in/assets/img/reactions/love.png)
![funny](https://news.sciencex.in/assets/img/reactions/funny.png)
![angry](https://news.sciencex.in/assets/img/reactions/angry.png)
![sad](https://news.sciencex.in/assets/img/reactions/sad.png)
![wow](https://news.sciencex.in/assets/img/reactions/wow.png)